Avacta has selected Tecan's Infinite M200 microplate reader to play a key role in offering analytical services to the biopharmaceutical sector.
Russell Hodgetts, managing director of Avacta's laboratory services, said: 'The Infinite M200 allows us to provide quality, high-throughout services to our clients, and is integral to the development of solubility screening assays, which are the starting point for our formulation development service.
'The multiple detection methods and environmental control available with the Tecan instrument make it extremely versatile,' he added.
Avacta has recently developed Midas (multi immuno diagnostic assay system), a point-of-care platform designed to automate medical diagnostic tests usually performed manually in a laboratory.
The Infinite plate reader has been central to this bioassay development, according to Avacta.
Dr Ed Quinn, product manager at Avacta, said: 'The multimode detection capabilities of the Infinite reader allow us to carry out a wide range of assaying techniques - using absorbance, fluorescence and luminescence detection - on one instrument, and the built-in temperature control and shaking mean that the complete assay can be performed in situ.
'The easy-to-use Icontrol software allows us to rapidly set up experiments, defining our own plate parameters to improve the resolution of our assays.
'Data is automatically exported to our laboratory information system, seamlessly integrating into our research and development programme.'
